Skip to content

Screener

Eligibility screening

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Po…

Sponsored by OHSU Knight Cancer InstituteStudy detailsClinicalTrials.gov

1 US site in OR

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.